Canopy Growth Technical Analysis: Dead Cat or Bounce?
Canopy Growth’s recent price action shows classic dead-cat bounce characteristics. At $1.12, the stock is testing resistance that has failed multiple times over the past 18 months. Technical traders…
Sanity Group Synergies: Where the Real Value Hides
Organigram’s €227M commitment to Sanity Group assumes meaningful synergies on the back end. Analysis of Sanity’s German operations reveals cost consolidation opportunities, but regulatory and…
The Unit Economics Crisis: Why GTI’s Expansion Slows
Green Thumb Industries’ aggressive store expansion has slowed not because of capital constraints, but because unit economics in new markets are deteriorating. Each new store requires higher capex and…
Curaleaf’s Cash Runway: The 18-Month Countdown
Curaleaf Holdings’ \$500M loan comes with a ticking clock. At current cash burn rates, the capital provides approximately 18-24 months of operational runway before the company faces a critical…
The Legalization Wildcard: Why 2026 Is Different This Time
If federal legalization passes in 2026, cannabis stocks could see a 30-50% rerating in 6 months. The market is pricing in ZERO probability. That’s the opportunity.